Retinoblastoma Has Properties of a Cone Precursor Tumor and Depends Upon Cone-Specific MDM2 Signaling

Cell

Volumn 137, Issue 6, 2009, Pages 1018-1031

  Xu, Xiaoliang L ^a,b   Fang, Yuqiang ^b   Lee, Thomas C ^c   Forrest, Douglas ^d   Gregory Evans, Cheryl ^e   Almeida, Dena ^a   Liu, Aihong ^a   Jhanwar, Suresh C ^b   Abramson, David H ^a,b   Cobrinik, David ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

HUMDISEASE; SIGNALING; STEMCELL

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; PROTEIN MDM2; RETINOBLASTOMA PROTEIN; RETINOID X RECEPTOR GAMMA; THYROID HORMONE RECEPTOR BETA; THYROID HORMONE RECEPTOR BETA2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BINDING SITE; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; MOUSE; NONHUMAN; ONCOGENE C MYB; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA CONE; RETINOBLASTOMA; SIGNAL TRANSDUCTION;

EID: 66449114034     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2009.03.051     Document Type: Article

References (55)

1. Abramson D.H., and Gombos D.S. The topography of bilateral retinoblastoma lesions. Retina 16 (1996) 232-239
2. Ajioka I., Martins R.A., Bayazitov I.T., Donovan S., Johnson D.A., Frase S., Cicero S.A., Boyd K., Zakharenko S.S., and Dyer M.A. Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice. Cell 131 (2007) 378-390
3. Bibb L.C., Holt J.K., Tarttelin E.E., Hodges M.D., Gregory-Evans K., Rutherford A., Lucas R.J., Sowden J.C., and Gregory-Evans C.Y. Temporal and spatial expression patterns of the CRX transcription factor and its downstream targets. Critical differences during human and mouse eye development. Hum. Mol. Genet. 10 (2001) 1571-1579
4. Bogenmann E., Lochrie M.A., and Simon M.I. Cone cell-specific genes expressed in retinoblastoma. Science 240 (1988) 76-78
5. Chen D., Livne-bar I., Vanderluit J.L., Slack R.S., Agochiya M., and Bremner R. Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 5 (2004) 539-551
6. Chen D., Opavsky R., Pacal M., Tanimoto N., Wenzel P., Seeliger M.W., Leone G., and Bremner R. Rb-mediated neuronal differentiation through cell-cycle-independent regulation of E2f3a. PLoS Biol. 5 (2007) e179
7. Christophorou M.A., Ringshausen I., Finch A.J., Swigart L.B., and Evan G.I. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature 443 (2006) 214-217
8. Cobrinik D. Pocket proteins and cell cycle control. Oncogene 24 (2005) 2796-2809
9. Cobrinik D., Francis R.O., Abramson D.H., and Lee T.C. Rb induces a proliferative arrest and curtails Brn-2 expression in retinoblastoma cells. Mol. Cancer 5 (2006) 72
10. Cornish E.E., Xiao M., Yang Z., Provis J.M., and Hendrickson A.E. The role of opsin expression and apoptosis in determination of cone types in human retina. Exp. Eye Res. 78 (2004) 1143-1154
11. Corson T.W., and Gallie B.L. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosomes Cancer 46 (2007) 617-634
12. Danko C.G., McIlvain V.A., Qin M., Knox B.E., and Pertsov A.M. Bioinformatic identification of novel putative photoreceptor specific cis-elements. BMC Bioinformatics 8 (2007) 407
13. Dannenberg J.H., Schuijff L., Dekker M., van der Valk M., and te Riele H. Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130. Genes Dev. 18 (2004) 2952-2962
14. Dimaras H., Khetan V., Halliday W., Orlic M., Prigoda N.L., Piovesan B., Marrano P., Corson T.W., Eagle Jr. R.C., Squire J.A., et al. Loss of RB1 induces non-proliferative retinoma; increasing genomic instability correlates with progression to retinoblastoma. Hum. Mol. Genet. 17 (2008) 1363-1372
15. Donovan S.L., Schweers B., Martins R., Johnson D., and Dyer M.A. Compensation by tumor suppressor genes during retinal development in mice and humans. BMC Biol. 4 (2006) 14
16. Dowhan D.H., Downes M., Sturm R.A., and Muscat G.E. Identification of deoxyribonucleic acid sequences that bind retinoid-X receptor-gamma with high affinity. Endocrinology 135 (1994) 2595-2607
17. Efeyan A., Garcia-Cao I., Herranz D., Velasco-Miguel S., and Serrano M. Tumour biology: Policing of oncogene activity by p53. Nature 443 (2006) 159
18. Elison J.R., Cobrinik D., Claros N., Abramson D.H., and Lee T.C. Small molecule inhibition of HDM2 leads to p53-mediated cell death in retinoblastoma cells. Arch. Ophthalmol. 124 (2006) 1269-1275
19. Friend S.H., Bernards R., Rogelj S., Weinberg R.A., Rapaport J.M., Albert D.M., and Dryja T.P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323 (1986) 643-646
20. Furukawa T., Morrow E.M., Li T., Davis F.C., and Cepko C.L. Retinopathy and attenuated circadian entrainment in Crx-deficient mice. Nat. Genet. 23 (1999) 466-470
21. Gallie B.L., Campbell C., Devlin H., Duckett A., and Squire J.A. Developmental basis of retinal-specific induction of cancer by RB mutation. Cancer Res. 59 (1999) 1731s-1735s
22. Gonzalez-Fernandez F., Lopes M.B., Garcia-Fernandez J.M., Foster R.G., De Grip W.J., Rosemberg S., Newman S.A., and VandenBerg S.R. Expression of developmentally defined retinal phenotypes in the histogenesis of retinoblastoma. Am. J. Pathol. 141 (1992) 363-375
23. Hendrickson A., and Provis J. Comparison of development of the primate fovea centralis with peripheral retina. In: Sernagor E., Eglen S., Harris B., and Wong R. (Eds). Retinal Development (2006), Cambridge University Press, Cambridge 126-149
24. Hernando E., Nahle Z., Juan G., Diaz-Rodriguez E., Alaminos M., Hemann M., Michel L., Mittal V., Gerald W., Benezra R., et al. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430 (2004) 797-802
25. Hurwitz R.L., Bogenmann E., Font R.L., Holcombe V., and Clark D. Expression of the functional cone phototransduction cascade in retinoblastoma. J. Clin. Invest. 85 (1990) 1872-1878
26. Iaquinta P.J., and Lees J.A. Life and death decisions by the E2F transcription factors. Curr. Opin. Cell Biol. 19 (2007) 649-657
27. Kato M.V., Shimizu T., Ishizaki K., Kaneko A., Yandell D.W., Toguchida J., and Sasaki M.S. Loss of heterozygosity on chromosome 17 and mutation of the p53 gene in retinoblastoma. Cancer Lett. 106 (1996) 75-82
28. Kleinerman R.A., Tucker M.A., Tarone R.E., Abramson D.H., Seddon J.M., Stovall M., Li F.P., and Fraumeni Jr. J.F. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J. Clin. Oncol. 23 (2005) 2272-2279
29. Kondo Y., Kondo S., Liu J., Haqqi T., Barnett G.H., and Barna B.P. Involvement of p53 and WAF1/CIP1 in gamma-irradiation-induced apoptosis of retinoblastoma cells. Exp. Cell Res. 236 (1997) 51-56
30. Kowalik T.F., DeGregori J., Leone G., Jakoi L., and Nevins J.R. E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2. Cell Growth Differ. 9 (1998) 113-118
31. Laurie N.A., Donovan S.L., Shih C.S., Zhang J., Mills N., Fuller C., Teunisse A., Lam S., Ramos Y., Mohan A., et al. Inactivation of the p53 pathway in retinoblastoma. Nature 444 (2006) 61-66
32. Lee T.C., Almeida D., Claros N., Abramson D.H., and Cobrinik D. Cell cycle-specific and cell type-specific expression of Rb in the developing human retina. Invest. Ophthalmol. Vis. Sci. 47 (2006) 5590-5598
33. Lomazzi M., Moroni M.C., Jensen M.R., Frittoli E., and Helin K. Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry. Nat. Genet. 31 (2002) 190-194
34. Maat-Kievit J.A., Oepkes D., Hartwig N.G., Vermeij-Keers C., van Kamp I.L., and van de Kamp J.J. A large retinoblastoma detected in a fetus at 21 weeks of gestation. Prenat. Diagn. 13 (1993) 377-384
35. MacPherson D., Sage J., Kim T., Ho D., McLaughlin M.E., and Jacks T. Cell type-specific effects of Rb deletion in the murine retina. Genes Dev. 18 (2004) 1681-1694
36. MacPherson D., Conkrite K., Tam M., Mukai S., Mu D., and Jacks T. Murine bilateral retinoblastoma exhibiting rapid-onset, metastatic progression and N-myc gene amplification. EMBO J. 26 (2007) 784-794
37. Mori M., Ghyselinck N.B., Chambon P., and Mark M. Systematic immunolocalization of retinoid receptors in developing and adult mouse eyes. Invest. Ophthalmol. Vis. Sci. 42 (2001) 1312-1318
38. Munier F.L., Balmer A., van Melle G., and Gailloud C. Radial asymmetry in the topography of retinoblastoma. Clues to the cell of origin. Ophthalmic Genet. 15 (1994) 101-106
39. Ng L., Hurley J.B., Dierks B., Srinivas M., Salto C., Vennstrom B., Reh T.A., and Forrest D. A thyroid hormone receptor that is required for the development of green cone photoreceptors. Nat. Genet. 27 (2001) 94-98
40. Ng L., Ma M., Curran T., and Forrest D. Developmental expression of thyroid hormone receptor beta2 protein in cone photoreceptors in the mouse. Neuroreport 20 (2009) 627-631
41. Nork T.M., Schwartz T.L., Doshi H.M., and Millecchia L.L. Retinoblastoma. Cell of origin. Arch. Ophthalmol. 113 (1995) 791-802
42. Pacal M., and Bremner R. Insights from animal models on the origins and progression of retinoblastoma. Curr. Mol. Med. 6 (2006) 759-781
43. Rich K.A., Zhan Y., and Blanks J.C. Migration and synaptogenesis of cone photoreceptors in the developing mouse retina. J. Comp. Neurol. 388 (1997) 47-63
44. Robanus-Maandag E., Dekker M., van der Valk M., Carrozza M.L., Jeanny J.C., Dannenberg J.H., Berns A., and te Riele H. p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev. 12 (1998) 1599-1609
45. Roberts M.R., Hendrickson A., McGuire C.R., and Reh T.A. Retinoid X receptor gamma is necessary to establish the S-opsin gradient in cone photoreceptors of the developing mouse retina. Invest. Ophthalmol. Vis. Sci. 46 (2005) 2897-2904
46. Rodrigues M.M., Rajagopalan S., Lee L., Nair C.N., Advani S.H., Donoso L., Chader G.J., and Wiggert B. Retinoblastoma: messenger RNA for interphotoreceptor retinoid binding protein. Curr. Eye Res. 11 (1992) 425-433
47. Schlamp C.L., Poulsen G.L., Nork T.M., and Nickells R.W. Nuclear exclusion of wild-type p53 in immortalized human retinoblastoma cells. J. Natl. Cancer Inst. 89 (1997) 1530-1536
48. Shachaf C.M., Gentles A.J., Elchuri S., Sahoo D., Soen Y., Sharpe O., Perez O.D., Chang M., Mitchel D., Robinson W.H., et al. Genomic and proteomic analysis reveals a threshold level of MYC required for tumor maintenance. Cancer Res. 68 (2008) 5132-5142
49. Skapek S.X., Pan Y.R., and Lee E.Y. Regulation of cell lineage specification by the retinoblastoma tumor suppressor. Oncogene 25 (2006) 5268-5276
50. Spencer C., Pajovic S., Devlin H., Dinh Q.D., Corson T.W., and Gallie B.L. Distinct patterns of expression of the RB gene family in mouse and human retina. Gene Expr. Patterns 5 (2005) 687-694
51. Swain P.K., Hicks D., Mears A.J., Apel I.J., Smith J.E., John S.K., Hendrickson A., Milam A.H., and Swaroop A. Multiple phosphorylated isoforms of NRL are expressed in rod photoreceptors. J. Biol. Chem. 276 (2001) 36824-36830
52. Szel A., Rohlich P., Mieziewska K., Aguirre G., and van Veen T. Spatial and temporal differences between the expression of short- and middle-wave sensitive cone pigments in the mouse retina: a developmental study. J. Comp. Neurol. 331 (1993) 564-577
53. Virtanen I., Kivela T., Bugnoli M., Mencarelli C., Pallini V., Albert D.M., and Tarkkanen A. Expression of intermediate filaments and synaptophysin show neuronal properties and lack of glial characteristics in Y79 retinoblastoma cells. Lab. Invest. 59 (1988) 649-656
54. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell 81 (1995) 323-330
55. Weller C.V. Intrinsic factors in the etiology of neoplasms. Am. J. Cancer 30 (1937) 39-46